Trial Profile

A Proof of Concept Study for GSK2248761 (An Extension of NV-05A-002: A Phase I/IIa Double-Blind Study to Evaluate the Safety and Tolerability, Antiretroviral Activity, Pharmacokinetics and Pharmacodynamics of IDX12899 in Antiretroviral Treatment-Naive HIV-1 Infected Subjects, Completed by Idenix)

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 24 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fosdevirine (Primary) ; Antiretrovirals; Lopinavir/ritonavir
Indications HIV-1 infections
Focus Adverse reactions; Pharmacokinetics; Proof of concept; Therapeutic Use
Sponsors ViiV Healthcare

06 Feb 2012 Results of parent and extension studies published in Antimicrobial Agents and Chemotherapy.
14 Sep 2010 Results of parent study were presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
12 Jan 2010 Status of extension study changed from recruiting to completed as reported by ClinicalTrials.gov

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com